Zeria Pharmaceutical Co., Ltd. logo

Zeria Pharmaceutical Co., Ltd. (4559)

Market Closed
10 Aug, 06:00
JPX JPX
¥
2,057. 00
+22
+1.0811%
¥
90.54B Market Cap
- P/E Ratio
50% Div Yield
97,200 Volume
- Eps
¥ 2,035
Previous Close
Add Transaction
Day Range
2,032 2,062
Year Range
1,878 2,434
Want to track 4559 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4559 closed yesterday higher at ¥2,057, an increase of 1.0811% from Friday's close, completing a monthly increase of 1.5301% or ¥31. Over the past 12 months, 4559 stock lost -1.0106%.
4559 pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of ¥25.
The last earnings report, released on May 07, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Zeria Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on Sep 26, 2013.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on JPX (JPY).

4559 Chart

People also search for

KYB Corporation
¥ 4,610
+1.4301%
Kissei Pharmaceutical Co. Ltd.
¥ 4,115
-0.8434%
Exedy Corporation
¥ 6,040
+1.0033%
Seiren Co., Ltd.
¥ 3,435
+0.1458%
Dcm Holdings Co., Ltd.
¥ 1,559
+0.7106%

Zeria Pharmaceutical Co., Ltd. (4559) FAQ

What is the stock price today?

The current price is ¥2,057.00.

On which exchange is it traded?

Zeria Pharmaceutical Co., Ltd. is listed on JPX.

What is its stock symbol?

The ticker symbol is 4559.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 50%.

What is its market cap?

As of today, the market cap is 90.54B.

Has Zeria Pharmaceutical Co., Ltd. ever had a stock split?

Zeria Pharmaceutical Co., Ltd. had 1 splits and the recent split was on Sep 26, 2013.

Zeria Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Sachiaki Ibe CEO
JPX Exchange
JP3428850006 ISIN
Japan Country
1,746 Employees
29 Sep 2026 Last Dividend
26 Sep 2013 Last Split
- IPO Date

Overview

Zeria Pharmaceutical Co., Ltd., founded in 1955 and headquartered in Tokyo, Japan, is a diversified pharmaceutical company engaged in the manufacturing, selling, importing, and exporting a broad spectrum of products. The company operates globally, offering pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents. Beyond its pharmaceutical focus, Zeria provides a wide range of other products including cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, and more. Initially called Zeria Yakusho Kenkyusho Co., Ltd., the company adopted its current name in May 1970, reflecting its broadened scope and international reach.

Products and Services

Pharmaceuticals: Zeria Pharmaceutical Co., Ltd. offers an extensive lineup in the gastrointestinal field, including treatments for functional dyspepsia, ulcerative colitis, Crohn's disease, gastritis, ulcers, and more. Their innovative portfolio also includes zinc containing anti-ulcerants, oral bowel cleansing agents, laxatives, therapeutic agents for hypophosphatemia, and iron deficiency anemia, among others.

Non-Pharmaceutical Products: The company extends its offerings to cosmetics, health foods, alcoholic beverages, soft drinks, food additives, and livestock feed, catering to various consumer needs beyond pharmaceuticals.

Medical Devices and Health Equipment: Zeria provides a range of medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment, designed to meet the rigorous standards of the healthcare industry and consumer health and beauty needs.

Consumer Healthcare Products: The company also markets consumer healthcare products including nutritional health drugs, remedies for gastrointestinal diseases, western herbal medicines, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorrhoidal remedies, and dermal remedies. Furthermore, Zeria offers quasi-drugs/cosmetics, nutrient tonics, soft drinks/health foods, and food for specified health uses, broadening its reach in the consumer health market.

Contact Information

Address: 10-11 Nihonbashi Kobuna-cho
Phone: 81 3 3663 2351